We are live on ! Find out more
TPCW

TD Private Client Wealth Portfolio holdings

AUM $4.82B
1-Year Est. Return 15.21%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+15.21%
3 Year Est. Return
+48.23%
5 Year Est. Return
+55.79%
10 Year Est. Return
AUM
$2.34B
AUM Growth
+$201M
Cap. Flow
+$64.6M
Cap. Flow %
2.76%
Top 10 Hldgs %
28.56%
Holding
1,242
New
77
Increased
537
Reduced
346
Closed
23

Top Sells

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$3.44M
2
ETN icon
Eaton
ETN
+$3.32M
3
PNC icon
PNC Financial Services
PNC
+$2.92M
4
MO icon
Altria Group
MO
+$2.86M
5
MCD icon
McDonald's
MCD
+$2.82M

Sector Composition

Rank Sector Weight
1 Technology 10.82%
2 Financials 7.85%
3 Healthcare 7.29%
4 Communication Services 5.12%
5 Industrials 4.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SITC icon
1001
SITE Centers
SITC
$224M
$3.18K ﹤0.01%
270
SCL icon
1002
Stepan Co
SCL
$1.33B
$3.13K ﹤0.01%
26
JHX icon
1003
James Hardie Industries
JHX
$14.9B
$3.04K ﹤0.01%
89
-1
-1% -$34
PEN icon
1004
Penumbra
PEN
$12.5B
$3.02K ﹤0.01%
11
QGEN icon
1005
Qiagen
QGEN
$8.52B
$2.95K ﹤0.01%
58
-677
-92% -$35K
OKTA icon
1006
Okta
OKTA
$23.9B
$2.94K ﹤0.01%
12
FLO icon
1007
Flowers Foods
FLO
$1.65B
$2.9K ﹤0.01%
120
PCY icon
1008
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.37B
$2.9K ﹤0.01%
105
-1,281
-92% -$35.2K
KDP icon
1009
Keurig Dr Pepper
KDP
$40.3B
$2.85K ﹤0.01%
81
NGVT icon
1010
Ingevity
NGVT
$2.58B
$2.85K ﹤0.01%
35
-2
-5% -$161
IOVA icon
1011
Iovance Biotherapeutics
IOVA
$2.24B
$2.78K ﹤0.01%
107
+48
+81% +$1.25K
CNMD icon
1012
CONMED
CNMD
$1.27B
$2.75K ﹤0.01%
+20
New +$2.74K
PTC icon
1013
PTC
PTC
$13.3B
$2.68K ﹤0.01%
19
+7
+58% +$957
SNN icon
1014
Smith & Nephew
SNN
$12.7B
$2.61K ﹤0.01%
60
WSM icon
1015
Williams-Sonoma
WSM
$26B
$2.55K ﹤0.01%
32
-3,386
-99% -$288K
EXEL icon
1016
Exelixis
EXEL
$13.9B
$2.55K ﹤0.01%
140
NVAX icon
1017
Novavax
NVAX
$1.26B
$2.55K ﹤0.01%
+12
New +$2.2K
ALE
1018
DELISTED
Allete
ALE
$2.52K ﹤0.01%
36
+31
+620% +$2.16K
CRWD icon
1019
CrowdStrike
CRWD
$187B
$2.51K ﹤0.01%
40
LCII icon
1020
LCI Industries
LCII
$2.54B
$2.5K ﹤0.01%
+19
New +$2.67K
DEI icon
1021
Douglas Emmett
DEI
$2.05B
$2.49K ﹤0.01%
74
CBT icon
1022
Cabot Corp
CBT
$4.62B
$2.45K ﹤0.01%
43
SFBS
1023
ServisFirst Bancshares
SFBS
$4.77B
$2.45K ﹤0.01%
+36
New +$2.38K
NVT icon
1024
nVent Electric
NVT
$25.1B
$2.4K ﹤0.01%
77
+47
+157% +$1.45K
PGRE
1025
DELISTED
Paramount Group
PGRE
$2.35K ﹤0.01%
233

Similar funds

TD Private Client Wealth's Q2 2021 Portfolio in Review

As of Q2 2021, TD Private Client Wealth held 1,242 positions worth $2.34B, up 9.4% from $2.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

TD Private Client Wealth's Q2 2021 filing shows 77 new, 537 increased, 346 reduced and 23 closed positions. Its largest new stake was Marvell Technology: 26,199 shares worth $1.53M. The largest sale was Dow Inc, an estimated $3.44M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • TD Private Client Wealth's largest Q2 2021 buy was Marvell Technology: 26,199 shares worth $1.53M.
  • TD Private Client Wealth added most to Vanguard Short-Term Corporate Bond ETF in Q2 2021, an estimated $28M increase.
  • TD Private Client Wealth's biggest Q2 2021 reduction was Dow Inc, cutting an estimated $3.44M.
  • TD Private Client Wealth fully exited VanEck Intermediate Muni ETF in Q2 2021, selling an estimated $483K.
  • TD Private Client Wealth's ten largest holdings make up 29% of its $2.34B portfolio in Q2 2021.
  • TD Private Client Wealth opened 77 new positions and closed 23 in Q2 2021.
  • TD Private Client Wealth's portfolio value rose 9.4% quarter-over-quarter to $2.34B.

Based on TD Private Client Wealth's 13F filing for Q2 2021, filed 16 Aug 2024.